Mastic Gum and Helicobacter Pylori eradication: an in vivo pilot study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN01756929

Enrollment

Registered

2008-04-29

Start date

2006-12-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Helicobacter pylori gastritis Infections and Infestations Gastritis and duodenitis

Interventions

Patients positive to Helicobacter pylori will be randomised to receive one of the following: 1. Mastic gum 2 g per day for 14 days 2. Mastic gum 2 g per day and pantoprazole 40 mg per day for 14 day

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. Patients tested positive for H. pylori 2. Adults of either sex aged between 18 and 75 years of age

Exclusion criteria

Exclusion criteria: 1. Pregnancy 2. Malignancy 3. Allergies to pantoprazole, amoxicillin, clarithromycin

Design outcomes

Primary

Measure	Time frame
Eradication of Helicobacter pylori, measured at five weeks after the end of treatment.	—

Secondary

Measure	Time frame
Helicobacter pylori load in patients remaining H. pylori positive, measured at five weeks after the end of treatment.	—

Countries

Greece

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026